Form D · Venture Capital Fund
Good Life Sciences Generations Fund I LP
Charleston, SC · CIK 0002108830
Offering snapshot reported May 26, 2026 · SEC filing
- Reported sold
- $1.5M Indefinite offering
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 18, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 26, 2026 | Initial | $1,500,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C.1, 3C
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-585131
Source: Form D, filed May 26, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Crutchfield | Director |
| John Friedman | Director |
| N/A Good Life Sciences Generations Fund I Gp Llc | Director, Promoter |
| David Mendez | Executive |
| Catherine Mohr, Md | Director |
| Lawrence Olanoff, Md, Ph D | Director |
| Amy Salzhauer | Director |
| Lonny Yarmus, Do, Mba, Ph D | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
251 1/2 King Street Suite 302
Charleston, SC, 29401
Charleston, SC, 29401